Global Medical Cannabis Market Key Insights:
The global medical cannabis market attained a value of more than USD 13 billion in 2018. The market is projected to witness a robust growth in the coming years, growing at a CAGR of around 23% between 2019-2024.
Get a Free Sample Report - https://www.expertmarketresearch.com/request?type=report&id=170&flag=B
North America is the leading cannabis market. The regional market is being aided by the legalisation drives for the drug for both, medical and recreational purposes. Almost 1.9 million people in North America were legally using the substance in 2017 to manage and relieve conditions like polymorphic seizures and chronic pain. With over 60% of the population in the region residing in areas with legalised medical cannabis, the industry is expected to witness a healthy growth in the forecast period. In 2018, the total cannabis sales in the US was estimated to be around USD 7.6 billion. As of January 2019, 33 states in the US along with Washington, DC had legalised marijuana use for medical purposes, which will aid the industry growth in the coming years. In Canada, the overall industry, including medical and legal along with illegal products, is expected to generate a sales revenue of nearly USD 1.7 billion in 2019 and the contribution of medical sales is anticipated to account for about one-fourth of the total industry sales in Canada. The industry is being driven by increased legalisation and the willingness of consumers to spend more on legal products.
In 2018, medical cannabis retail sales reached around USD 3.7 billion in the US. Europe is another leading market which is expected to grow annually by € 35.7 billion. With people spending nearly € 1.49 trillion on healthcare in 2017 on the continent, the industry has a high potential for growth in the region. The medical marijuana industry is a key expansion sector for pharmaceutical companies in Europe. Germany represents the leading market for medical cannabis in the region and was worth USD 11.9 billion in 2017. The Western European country imports most of its supply from Canada, and is looking to expand its domestic supply to meet the rising local demand.
Properties and Applications
Cannabis, also known as marijuana, is a psychotropic drug which is derived from the cannabis plant. It is consumed within food or as an extract or by smoking or vaporising. Historically, the substance has been used medicinally by the Indian, Egyptian, Chinese and Islamic cultures. Currently, it is finding extensive use in treating or relieving symptoms related to chronic pain, arthritis, epilepsy, Parkinson’s, Tourette’s, AIDS, and cancer, among others. Its application can be broadly divided into:
Cannabis is found in dried and extract forms, and can be derived from the Indica or Sativa species. It can also be derived from a hybrid species containing traces of both, Indica and Sativa. Currently, Indica has the largest market share and is used to treat headaches, migraines, and other body pains. Based on the dominant compound the substance can be divided into:
CBD finds extensive application in the medical sector due to being non-psychoactive. THC, on the other hand, is used to alleviate the side-effects from the treatments of cancer and AIDS. Cannabis for medicinal use is distributed through dispensaries, pharmacies, and online retailers. The major regional markets for medical cannabis are North America, Europe, LATAM, Asia Pacific, and Middle East and Africa.
The global medical cannabis market is being aided by the rising legalisation of marijuana for medical usage as well as a growing acceptance of the substance by the potential consumers. The rising number of R & D undertakings, clinical trials, and increased commercialisation of the product will also drive the industry growth. Israel is a significant market in terms of the research and development investments into medical marijuana. The country has led multiple pioneering studies in the field including the effect of medicinal cannabis on autistic people. With regulatory authorities in the US like the National Institute on Drug Abuse and the Drug Enforcement Agency hindering the expansion of research on the subject, several US companies are conducting research in Israel and investing in the Israeli cannabis industry. In Canada, the industry for medicinal marijuana is being driven by the willingness of Canadian insurance companies to reimburse the utilisation of cannabis to treat conditions like cancer-related pain and nausea, spasticity caused by multiple sclerosis, rheumatoid arthritis pain, HIV/AIDS, and other palliative care.
Globally, the industry is also finding impetus for its growth in the rising population of geriatrics who are more vulnerable to chronic illnesses and are likely to suffer from pain related to conditions like rheumatoid arthritis. The increasing disposable income is also likely to drive the industry. The growing consumer awareness about the product is also proving to be a catalyst for the market. The industry is further aided by consumer satisfaction with cancer patients who have used medicinal cannabis testifying to the product’s contribution to the improvement of their quality of life by relieving pain and the side-effects of chemotherapy like nausea. Medical cannabis is also viewed as a safer option over opioid-based prescription medications.
The report analyses the following key players in the global medical cannabis market, looking into their market share, capacity, and latest developments like mergers and acquisitions, capacity expansions, and plant turnarounds:
The EMR report gives an in-depth insight into the market, providing a SWOT analysis as well as an analysis of Porter’s Five Forces.
2 Research Methodology
3 Executive Summary
3.1 Market Overview
3.2 Key Demand Drivers
3.3 Key Players
3.4 Supply Market Changes
4 Global Medical Cannabis Market Overview
4.1 Global Medical Cannabis Market Analysis
4.1.1 Figure: Global Medical Cannabis Historical Market (2014-2018) & Forecast (2019-2024)
4.1.2 Figure: Global Medical Cannabis Market Breakup by Product Type: Historical Market (2014-2018) & Forecast (2019-2024)
22.214.171.124 Dried Form
126.96.36.199 Extract Form
4.1.3 Figure: Global Medical Cannabis Market Breakup by Species: Historical Market (2014-2018) & Forecast (2019-2024)
4.1.4 Figure: Global Medical Cannabis Market Breakup by Compound: Historical Market (2014-2018) & Forecast (2019-2024)
188.8.131.52 Balanced THC & CBD
4.1.5 Figure: Global Medical Cannabis Market Breakup by Application: Historical Market (2014-2018) & Forecast (2019-2024)
184.108.40.206 Pain Management
4.1.6 Figure: Global Medical Cannabis Market Breakup by Distribution Channel: Historical Market (2014-2018) & Forecast (2019-2024)
220.127.116.11 Online Retailers
4.1.7 Chart: Global Medical Cannabis Market Breakup by Region
18.104.22.168 North America
22.214.171.124 Asia Pacific
126.96.36.199 Middle East & Africa
4.1.8 Figure: Regional Medical Cannabis Historical Market (2014-2018) & Forecast (2019-2024)
188.8.131.52 North America
184.108.40.206 Asia Pacific
220.127.116.11 Middle East & Africa
4.2 SWOT Analysis
4.3 Value Chain Analysis
4.4 Porter’s Five Forces Analysis
4.4.2 Buyer’s Power
4.4.3 Supplier’s Power
4.4.4 New Entrants
4.4.5 Degree of Rivalry
4.5 Global (HS Code-5302 Sativa L) Trade Analysis (2018)
4.5.1 Major Exporting Countries by Value & Volume
4.5.2 Major Importing Countries by Value & Volume
4.6 Global Medical Cannabis Price Analysis
4.6.1 North America Medical Cannabis Historical Price Trends (2014-2018) & Forecast (2019- 2024)
4.6.2 Europe Medical Cannabis Historical Price Trends (2014-2018) & Forecast (2019-2024)
4.6.3 Asia Pacific Medical Cannabis Historical Price Trends (2014-2018) & Forecast (2019-2024)
4.6.4 LATAM Medical Cannabis Historical Price Trends (2014-2018) & Forecast (2019-2024)
4.6.5 Middle East & Africa Country Medical Cannabis Historical Price Trends (2014-2018) & Forecast (2019-2024)
5 Competitive Landscape & Supplier Analysis
5.2 Bedrocan International
5.3 Canopy Growth Corporation
5.4 Aurora Cannabis Inc.
5.5 Aphria Inc.
5.6 Terra Tech Corp.
5.7 Vivo Cannabis Inc.
5.8 Emerald Health Therapeutics, Inc
5.9 Cronos Group Inc.
5.10 Organigram Holdings Inc
6 Events and Developments
EMR is one of the foremost business intelligence and market research firms with a database of syndicated and customised reports spanning more than 100 industries across global and regional markets. We leverage the knowledge of our highly skilled team of over 100 analysts and more than 3000 independent consultants to provide our clients with thoroughly researched and reliable data tailored to their requirements. We help our clients, who range from Fortune 1000 companies to medium and niche enterprises, make informed strategic decisions through our varied tools and methodology.
Our meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. We understand the distinct nature and requirements for each market and thus, modify our methodology to best fit the industry in question. Our research methodology uses a combination of cutting-edge analytical tools and the expertise of our highly accomplished team, thus, providing our customers with market insights that are accurate, actionable, and help them remain ahead of their competition. EMR’ s fine-tuned research methodology and data analysis, formulated through years of cross-industry experience of our team, ensure that our clients are provided with:
Our approach gives our clients a comprehensive assessment of the prevailing and projected market conditions through the collection, collation, and analysis of data from trusted sources.
We assess the historical, prevailing, and expected prices of commodities and raw materials by analysing our assiduously collected data from verified primary and secondary sources. Our assessments reflect the market values of related commodities within a region to help our consumers understand the interdependencies and formulate profitable market strategies. Our price assessments cover both the average global prices along with the prevailing regional prices.
Our market assessments determine the global and regional production and consumption of the product, according to their value and volume. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future market growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions. We also take into account the demographic, economic, cultural, and political factors that might influence the market.
We gather market intelligence through our extensive database of reliable secondary sources and our exhaustive interviews with multiple industry stakeholders. The information gathered through our primary and secondary sources help us verify and extrapolate data relating to prices, trade, and market fluctuations along with the latest developments in the market.
As a part of our primary research, we interact with highly placed industrial professionals possessing an expansive and meticulous insight into the market. We conduct our interviews via mails, telephonic conversations, and one-on-one meetings. Thus, our exhaustive interviews with both buyers and consumers help us provide our clients with verified intelligence regarding the market size, share, drivers, prices, and forecast along with a detailed assessment of your supply chain.
EMR has access to extensive internal and subscribed databases, which apprise us of the historical and prevailing market conditions and help us forecast the market for the coming few years. Our secondary research involves a wide array of sources ranging from the annual and financial reports of the key players in the industry to governmental and regulatory databases. We refer to various scientific and industry publications and whitepapers to form a comprehensive understanding of the product and the supply chain. Our wide-ranging research also refers to relevant articles and press releases to provide our customers with an up-to-date understanding of the contemporary market. We derive extensive raw data from our secondary research, which then go through a thorough verification and validation process, to help us formulate an exhaustive understanding of the market, the supply chain, the competitive landscape, and the product.
Other Analyst Tools and Data Models
Our extensive and intricate data models, formulated through our propriety technological and analytical resources, help you easily comprehend the expansive market data and aid you in framing vital business and market strategies. Our tools provide you with a cohesive understanding of the industry outlook, taking into account the qualitative and quantitative market variables. Our analytical tools and models are regularly updated according to the changes in the continually evolving market scenarios as well as being adapted to best meet our client’s specific needs. Our research methods involve a blend of the best technological tools used in the industry along with the expertise of our analysts and consultants who can spot and assess the implications of the subtle factors influencing the more complex markets.
Our market assessments take into consideration only those data that are confirmed and are derived from credible and transparent sources. Thus, our clients are presented with accurate and infallible data which can be incorporated into their business strategies.
Before our data is presented to the clients, they undergo an intensive cross-verification and validation process. We corroborate the data gathered through our primary and secondary research by the review and validation of the initial sources along with the verification of the data from other thoroughly vetted sources.
Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions. By constantly updating our databases and reports to reflect the changes taking place in the market, our market and price assessments accurately reflect the prevailing industry conditions.
Thus, our rigorous data collection, thorough statistical analysis, and specialist assessments ensure that our clientele has a greater understanding of the market space, supply chain, price fluctuations, competitive landscape, and other vital factors, helping them emerge as the undisputed industry leaders in their respective fields.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Global Anaplastic Thyroid Cancer Drugs Market Report and Forecast 2019-2024
Asia Pacific Drug Development Market Report and Forecast 2019-2024
Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Report and Forecast 2019-2024
Global Phosphodiesterase (PDE) Inhibitors Market Report and Forecast 2019-2024
Buy Full Version
"Global Medical" Purchase Enquiry